Literature DB >> 13716809

Clinical experience with streptonigrin.

E W HUMPHREY, N BLANK.   

Abstract

Keywords:  ANTIBIOTICS/therapy; ANTINEOPLASTIC AGENTS/therapy

Mesh：

Substances：

Year:  1961        PMID： 13716809

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  3 in total

1.  Biological assay of streptonigrin (NSC 45383) in body fluids and tissues of mice.

Authors:  R F Pittillo; C Woolley
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

2.  Streptonigrin Inhibits SENP1 and Reduces the Protein Level of Hypoxia-Inducible Factor 1α (HIF1α) in Cells.

Authors:  Nigus Ambaye; Chih-Hong Chen; Swati Khanna; Yi-Jia Li; Yuan Chen
Journal:  Biochemistry       Date:  2018-03-01       Impact factor: 3.162

3.  Identification of (2S,3S)-β-Methyltryptophan as the Real Biosynthetic Intermediate of Antitumor Agent Streptonigrin.

Authors:  Dekun Kong; Yi Zou; Zhang Zhang; Fei Xu; Nelson L Brock; Liping Zhang; Zixin Deng; Shuangjun Lin
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.